The use of bevacizumab and ranibizumab for branch retinal vein occlusion in medicare beneficiaries.
Wu AM, Wu CM, Greenberg PB, Yu F, Lum F, Coleman AL. The use of bevacizumab and ranibizumab for branch retinal vein occlusion in medicare beneficiaries. Am J Ophthalmol Case Rep. 2018 Sep; 11:105-108.